Finance

Beta
Lists
POLYMED:NSE
Poly Medicure Ltd.
₹1,381.80
+3.18%
(+42.60) 1D
Jun 4, 1:23:28 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for POLYMED...
Open
₹1,335.20
High
₹1,383.80
Low
₹1,330.70
Mkt. cap
139.93B
Avg. vol.
171.10K
Volume
140.06K
P/E ratio
43.52
52-wk high
₹2,316.60
52-wk low
₹1,182.00
EPS
₹31.75
Shares outstanding
88.23M
No. of employees
3K
Open
₹1,335.20
High
₹1,383.80
Low
₹1,330.70
Mkt. cap
139.93B
Avg. vol.
171.10K
Volume
140.06K
P/E ratio
43.52
52-wk high
₹2,316.60
52-wk low
₹1,182.00
EPS
₹31.75
Shares outstanding
88.23M
No. of employees
3K
News stories
From sources across the web
About Poly Medicure Ltd.
CEO-
Employees3.08K
Founded1995
Headquarters-
SectorMedical device
Last report
May 25, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
₹6.53 / ₹7.98
-18.12%miss
Revenue / Est. (INR)
5.35B / 5.24B
+2.10%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
4.03B
4.44B
4.94B
5.35B
Cost of goods sold
1.27B
1.36B
1.56B
1.78B
Cost of revenue
1.27B
1.36B
1.56B
1.78B
Research and development expenses
66.80M
78.06M
59.58M
67.43M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
751.14M
888.26M
1.15B
1.26B
Operating expense
1.93B
2.18B
2.55B
2.84B
Total operating expenses
3.20B
3.54B
4.11B
4.62B
Operating income
828.81M
897.54M
824.27M
721.65M
Other non operating income
416.91M
339.44M
262.63M
177.56M
EBT including unusual items
1.23B
1.22B
976.12M
852.22M
EBT excluding unusual items
1.23B
1.22B
1.04B
852.22M
Income tax expense
298.63M
298.93M
268.04M
201.81M
Effective tax rate
24.29%
24.56%
27.46%
23.68%
Other operating expenses
880.47M
969.06M
1.06B
1.13B
Net income
930.83M
918.35M
709.30M
662.92M
Net profit margin
23.09%
20.69%
14.37%
12.40%
Earnings per share
9.17
9.06
7.48
6.53
Interest and investment income
-
-
-
-
Interest expense
-29.50M
-29.73M
-59.59M
-64.09M
Net interest expenses
-29.50M
-29.73M
-59.59M
-64.09M
Depreciation and amortization charges
232.58M
249.31M
287.56M
382.32M
EBITDA
1.04B
1.14B
1.03B
1.01B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more